At the same time, though, VAPB-null mice develop mild motor dysfunction (Kabashi et al. 2013), suggesting that loss of VAPB function alone might not be sufficient to justify the onset of ALS symptoms in patients. This evidence concerns the gene VAPB and amyotrophic lateral sclerosis.